AI Summary
This article discusses a study where an octavalent next-generation influenza vaccine was administered intranasally and found to elicit protective immune responses against both seasonal and pre-pandemic influenza viruses. The results suggest that this new vaccine approach could provide broader protection against influenza viruses, including those with pandemic potential.